Scancell’s cancer vaccine Modi-1 makes progress
Scancell’s phase I ModiFY trial assessing its cancer vaccine Modi-1 in various difficult-to-treat cancer types makes progress following a positive safety review.
Scancell’s phase I ModiFY trial assessing its cancer vaccine Modi-1 in various difficult-to-treat cancer types makes progress following a positive safety review.
Wonderhood commissioned for a new documentary on the Park Lane Hilton, further exhibiting its exciting slate.
Calculus Q2 2023 Quarterly Update showcasing some great news stories from our portfolio companies.
Arctic Shores are to work with some of the largest brewing brands on a new recruitment drive.
Its new documentary explores the legacy of famed music art studio Hipgnosis.
The new trial is designed to build on preliminary data supporting the notion that OBT-076 is able to deliver immune priming in chemo-refractory, advanced cancer patients.
The Annual General Meeting (AGM) of Calculus VCT plc will be held at 12pm on 21 of August 2023
Wonderhood’s latest production to premiere tells the tale of the British evacuation of Kabul in 2021 through military personnel’s experiences.
Arecor has a new level of protection for their proprietary insulin products in Europe and China.
Invizius continues to advance their work improving the lives of people requiring dialysis.
True, a platform designed to help business with their Net Zero strategy.
Brouhaha’s latest project impresses at prestigious Cannes Film Festival.
This encouraging research programme stems from a collaboration Destiny Pharma has with SporeGen Limited
The collaboration will see a new Phase 1b trial undertaken, investigating OBT’s lead asset, OBT076, in patients with Adenoid Cystic Carcinoma (ACC), a rare and aggressive type of cancer
The grant from the Medical Technology Enterprise Consortium (MTEC) will support the continued development of its fully portable handheld DeepView device
Brouhaha continue their progress with prestigious inclusion.
It is hoped that these reagents will help combat the growing wave of deaths in North America attributable to synthetic opioids
The initial administration of Arecor’s insulin candidate to a patient marks a significant step forward in the quest to transform the management of type 2 diabetes.
Their new film stars Jude Law, Alicia Vikander and Simon Russell Beale and is directed by Karim Aïnouz
CEO, John Glencross quoted in this article regarding the potential removal of the sunset clause.
Modi-1 cancer vaccine showed partial response and stable disease in patients with hard-to-treat head and neck, high grade serous ovarian or triple negative breast cancers.
John Glencross, Chief Executive of Calculus, is quoted in City AM, speaking about how EIS can mitigate inheritance tax.
New Calculus portfolio company Artic Shores helps companies revolutionise recruitment through their innovative technology.
Scancell continue to make significant strides in its efforts to develop novel immunotherapies for the treatment of cancer and infectious disease.